BioRem Inc.'s ( CVE:BRM ) strong earnings report was rewarded with a positive stock price move. We did some digging and...

As the Canadian market navigates through a period of uncertainty, marked by fluctuating energy supplies and geopolitical tensions, investors are keenly observing how these factors might influence future growth trajectories. Amidst this backdrop, penny stocks—despite their somewhat outdated label—continue to capture attention for their potential to offer value and growth opportunities at lower entry points. This article explores several promising penny stocks on the TSX that stand out for...

The Canadian market has been experiencing a robust earnings season, with the TSX showing solid growth and broad-based profit increases across multiple sectors. In this context, penny stocks—often smaller or newer companies—remain an intriguing investment area despite being somewhat of an outdated term. These stocks can offer unique growth opportunities when backed by strong financials and fundamentals, making them appealing to investors looking for hidden gems in the market.

Canadian equities have recently reached new record highs, buoyed by supportive signals from the Bank of Canada and the Federal Reserve. In this context, penny stocks—though a somewhat outdated term—still represent an intriguing investment area, often involving smaller or newer companies that can offer growth potential at lower price points. By focusing on those with robust financials and clear growth trajectories, investors may uncover promising opportunities within this niche market segment.

BioRem (BRM.V) up over 4% on last look, said Monday that third-quarter net income and revenue both f

The Canadian market is experiencing a mix of optimism and caution, with recent job growth surprising to the upside and AI-related enthusiasm driving both innovation and volatility. Amid this backdrop, penny stocks—typically smaller or newer companies—remain an intriguing investment area despite being considered somewhat outdated. When these stocks are supported by strong financial health, they can offer unique opportunities for growth at lower price points.

BioRem's (CVE:BRM) stock is up by 4.7% over the past week. Given that the market rewards strong financials in the...

BioRem (BRM.V) was up 10% at last look on Monday after saying second-quarter net earnings more than